| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | pyroglutamate | 9150373 | Peak area (top) | ML162 |
| Reversed phase NEGATIVE ION MODE | pyroglutamate | 9901959 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | pyroglutamate | 11063540 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | pyroglutamate | 11117630 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | pyroglutamate | 11205470 | Peak area (top) | ML162 |
| Reversed phase NEGATIVE ION MODE | pyroglutamate | 11639610 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | pyroglutamate | 11703510 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | pyroglutamate | 11917040 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | pyroglutamate | 12007770 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | pyroglutamate | 12037900 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | pyroglutamate | 12332970 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | pyroglutamate | 12445880 | Peak area (top) | ML162 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|